Omissão da radioterapia adjuvante no câncer de mama luminal A e rastreamento em mulheres canadenses de 40 a 49 anos

Referências:Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer - Timothy J. Whelan, B.M., B.Ch., Sally Smith, M.D., Sameer Parpia, Ph.D., Anthony W. Fyles, M.D., Anita Bane, M.B., Fei-Fei Liu, M.D., Eileen Rakovitch, M.D., Lynn Chang, M.D., Christiaan Stevens, M.D., Julie Bowen, M.D., Sawyna Provencher, M.D., Valerie Théberge, M.D., et al., for the LUMINA Study Investigators*. August 17, 2023. N Engl J Med 2023; 389:612-619. DOI: 10.1056/NEJMoa2302344 https://www.nejm.org/doi/full/....10.1056/NEJMoa230234 Impact of Breast Cancer Screening on 10-Year Net Survival in Canadian Women Age 40-49 Years - Anna N. Wilkinson, MD, MSc, CCFP; Larry F. Ellison, MSc2; Jean-Michel Billette, PhD; and Jean M. Seely, MD, FRCPC - DOI: 10.1200/JCO.23.00348 Journal of Clinical Oncology - Published online August 04, 2023. https://ascopubs.org/doi/full/10.1200/JCO.23.00348